Connect with us

Spread & Containment

WHO Official Admits Vaccine Passports May Have Been A Scam

WHO Official Admits Vaccine Passports May Have Been A Scam

Authored by Paul D. Thacker via The Disinformation Chronicle (subscribe here),

The…

Published

on

WHO Official Admits Vaccine Passports May Have Been A Scam

Authored by Paul D. Thacker via The Disinformation Chronicle (subscribe here),

The World Health Organization’s Dr. Hanna Nohynek testified in court that she advised her government that vaccine passports were not needed but was ignored, despite explaining that the COVID vaccines did not stop virus transmission and the passports gave a false sense of security. The stunning revelations came to light in a Helsinki courtroom where Finnish citizen Mika Vauhkala is suing after he was denied entry to a café for not having a vaccine passport.

Dr. Nohynek is chief physician at the Finnish Institute for Health and Welfare and serves as the WHO’s chair of Strategic Group of Experts on immunization. Testifying yesterday, she stated that the Finnish Institute for Health knew by the summer of 2021 that the COVID-19 vaccines did not stop virus transmission

During that same 2021 time period, the WHO said it was working to "create an international trusted framework" for safe travel while EU members states began rolling out COVID passports. The EU Digital COVID Certificate Regulation passed in July 2021 and more than 2.3 billion certificates were later issued. Visitors to France were banned if they did not have a valid vaccine passport which citizens had to carry to buy food at stores or to use public transport.

But Dr. Nohynek testified yesterday that her institute advised the Finnish government in late 2021 that COVID passports no longer made sense, yet certificates continued to be required. Finnish journalist Ike Novikoff reported the news yesterday after leaving the Helsinki courtroom where Dr. Nohynek spoke.

Dr. Nohynek’s admission that the government ignored scientific advice to terminate vaccine passports proved shocking as she is widely embraced in global medical circles. Besides chairing the WHO’s strategic advisory group on immunizations, Dr. Nohynek is one of Finland’s top vaccine advisors and serves on the boards of Vaccines Together and the International Vaccine Institute.

The EU’s digital COVID-19 certification helped establish the WHO Global Digital Health Certification Network in July 2023. “By using European best practices we contribute to digital health standards and interoperability globally—to the benefit of those most in need,” stated one EU official.

Finnish citizen Mika Vauhkala created a website discussing his case against Finland’s government where he writes that he launched his lawsuit “to defend basic rights” after he was denied breakfast in December 2021 at a Helsinki café because he did not have a COVID passport even though he was healthy. “The constitution of Finland guarantees that any citizen should not be discriminated against based on health conditions among other things,” Vauhkala states on his website.

Vauhkala’s lawsuit continued today in Helsinki district court where British cardiologist Dr. Aseem Malhotra will testify that, during the COVID pandemic, some authorities and medical professionals supported unethical, coercive, and misinformed policies such as vaccine mandates and vaccine passports, which undermined informed patient consent and evidence-based medical practice.

You can read Dr. Malhotra’s testimony here.

Tyler Durden Sun, 04/14/2024 - 15:10

Read More

Continue Reading

Spread & Containment

Mall retailer considers Chapter 11 bankruptcy as cash dwindles

The popular retail chain has been delisted from the New York Stock Exchange and it has met with its lenders to explore a possible bankruptcy filing.

Published

on

When retail chains show slowing chains they usually blame one of two boogeymen.

First, there's Amazon. The online retailer has changed how consumers shop, but it has not disrupted brick-and-mortar sales on the level most people believe. Online sales are still a relatively small piece of the overall retail market, according to data from the U.S. Bureau of Labor Statistics (BLS). 

"Fourth quarter 2023 e-commerce estimate increased 7.5% (±1.2%) from the fourth quarter of 2022 while total retail sales increased 2.8% (±0.4%) in the same period. E-commerce sales in the fourth quarter of 2023 accounted for 15.6% of total sales," the BLS shared in its quarterly report.

Related: Failed Chapter 11 bankruptcy puts fast food chain in final days

That number has been steady for years, climbing to about 20% during the lockdown period of the pandemic, but never reaching those levels again.

In addition to Amazon and the internet, failing retailers often blame falling mall traffic and that's not really a major issue either.

"Shopping mall foot traffic is nearing pre-pandemic levels, but not everything is the same — that’s a main takeaway from a new white paper by foot traffic analytics firm Placer.ai, titled 'The Comeback of the Mall in 2024.' The white paper finds that during 2023, visits at indoor malls were down 5.8% compared to 2019 — a dramatic improvement from being down more than 15% in 2021," Placer.ai shared.

Open-air shopping centers have done even better as traffic dropped only 1% last year compared to 2019.

"Visits for the shopping center industry at large were down 2.3%, and “foot traffic may yet pick up again in 2024,” according to the report.

Malls have seen their traffic go back to around pre-pandemic levels.

Image source: Getty Images

Retail chain faces a cash crunch

Express (EXPR) has struggled and the company had a net loss of $36.8 million in the third quarter, which is a similar number to its $34.4 million net loss in the same quarter a year ago. The company has nearly $500 million in inventory, but only $34.6 million cash and cash equivalents totaled $34.6 million. That's actually an improvement of $10 million from the same period a year ago.

Rapid Ratings, a company which uses publicly-available data to track a company's financial health, has called the company a "high default risk," and has warned its customers "begin mitigating risk."

Express has been working to cut its expenses to preserve liquidity."

"The company is continuing to conduct a comprehensive review of its business model to identify actions that are expected to meaningfully reduce pre-tax costs and enable a more efficient and effective organization and has engaged external advisors to assist in this effort. The company is reiterating its stated goal to deliver over $200 million in annualized savings by 2025 versus 2022," Express shared in its third quarter earnings report.

RapidRatings data, however, does show the company remains at risk for a default, but also had some potentially encouraging remarks. 

"Express Inc is situated in our High Risk group, displays weakness in three of our seven performance categories and demonstrates significant underperformance in ROCE. If current trends persist it would be logical to expect that Express Inc will face serious default risk this coming year although prospects for sustainable efficiency and competitiveness are promising over the medium-term; thus, the outlook is mixed," the service shared.

Express explores potential Chapter 11 filing

Express, which sells mid-priced men's and women's clothing, has been meeting with its lenders about funding a potential Chapter 11 bankruptcy filing Bloomberg reported. The company operates 530 Express retail and Express Factory Outlet stores in the United States and Puerto Rico, the Express.com online store and the Express mobile app, approximately 60 Bonobos Guideshop locations and the Bonobos.com online store,and 12 UpWest retail stores and the UpWest.com online store.

The retail chain has roughly $300 million in debt and expects to lose about $120 million for the full year. Express management has not made any public comment on a potential chapter 11 filing.

Express has not had an earnings call with analysts since Nov. 2023. CEO Stewart Glendinning, who joined the company in August 2023, tried to remain optimistic during that call.

"Our third quarter sales and diluted loss per share came in below the low end of our outlook ranges. The macroeconomic environment remains challenging and the consumer and competitive landscapes were highly promotional," he said.

The CEO was honest about the state of the company and its sales efforts.

"In the Express brand, unit sales were consistent with our expectations. However, moving through this inventory required more extensive discounting and led to greater gross margin erosion," he added.

Glendinning admitted that the company made some merchandise and operating mistakes.

"Across the Board, we have opportunities to improve our operating execution. This includes cycle times, in-store execution, sourcing logistics, all parts of our business which allow us to serve customers, lower our cost base and beat the competition. As part of this effort, we expect some rationalization of our store count as we close high effort, unprofitable stores," he shared.

 

 

 

Read More

Continue Reading

International

These Are Asia’s Richest Billionaires

These Are Asia’s Richest Billionaires

As of the start of April, Mukesh Ambani (66) is the richest man in Asia, with a net worth of $116.1…

Published

on

These Are Asia's Richest Billionaires

As of the start of April, Mukesh Ambani (66) is the richest man in Asia, with a net worth of $116.1 billion, according to Forbes’ Real-Time Billionaires List,

Ambani is the chairman of Reliance Industries Limited, a conglomerate that focuses not only on petrochemicals, but also textiles and telecommunications. As Statista's Anna Fleck reports, Ambani ranks 11th on Forbes’ worldwide list, which is headed by Bernard Arnault & family (LVMH) with $221.8 billion, Jeff Bezos (Amazon) with $197.5 billion and Elon Musk (Tesla, SpaceX, X formerly Twitter) with $189.0 billion.

You will find more infographics at Statista

In second place - and some 32.8 billion dollars behind - comes 61-year-old Gautam Adani who is the chairperson of the Adani Group, a conglomerate that deals with businesses exporting and importing raw materials and finished goods, including coal trading, mining, oil and gas exploration, as well as ports, energy and agricultural commodities.

He is succeeded by Zhong Shanshan (69), with a net worth of $64.5 billion. Shanshan is the founder of beverages company Nongfu Spring as well as the founder of Beijing Wantai Biological Pharmacy Enterprise, a private Chinese company and major supplier of Covid-19 testing kits.

Rounding off the top ten comes Savitri Jindal (74), the widow of Om Prakash Jindal who founded the Jindal Group in India, whose interests lay in steel, power, cement and infrastructure, with an estimated net worth of $34.8 billion, followed by Shiv Nadar (78), founder and chairman of the IT enterprise HCL Technologies, with $34.5 billion.

The top ten richest people in Asia have a total net worth of $542.1 billion.

Tyler Durden Sat, 04/13/2024 - 22:45

Read More

Continue Reading

Government

CDC Study Doesn’t ‘Debunk’ Link Between COVID-19 Vaccines & Sudden-Deaths

CDC Study Doesn’t ‘Debunk’ Link Between COVID-19 Vaccines & Sudden-Deaths

Authored by Zachary Stieber via The Epoch Times,

A new U.S….

Published

on

CDC Study Doesn't 'Debunk' Link Between COVID-19 Vaccines & Sudden-Deaths

Authored by Zachary Stieber via The Epoch Times,

A new U.S. Centers for Disease Control and Prevention (CDC) study does not disprove a link between COVID-19 vaccines and sudden deaths among young people, contrary to claims.

 

The study, published by the CDC’s quasi-journal on April 11, analyzed death certificates from Oregon for people aged 16 to 30 who died between June 2021 and December 2022.

Among people who died with evidence of vaccination, three died within 100 days of a shot, Drs. Juventila Liko and Paul Cieslak with the Oregon Health Authority found.

None of those three deaths could be attributed to messenger RNA (mRNA) vaccination, or shots from Pfizer-BioNTech and Moderna, according to the doctors. Two of the deaths were attributed to underlying conditions while the cause of death for the third was “undetermined.”

“These data do not support an association between receipt of mRNA COVID-19 vaccine and sudden cardiac death among previously healthy young persons,” the doctors wrote.

The authors failed to note that a much larger, peer-reviewed study from South Korea confirmed vaccine-induced myocarditis caused eight sudden cardiac deaths (SCDs), all among people younger than 45. Myocarditis is a form of heart inflammation.

The new study “is at odds with a higher quality and peer-reviewed journal article published in the European Heart Journal,” Dr. David McCune, who was not involved with either paper, told The Epoch Times via email. “The study, from Korea, found a small but significant group of patients who had SCD and autopsy evidence consistent with vaccine-induced myocarditis.”

Multiple media outlets published stories on the new study, but none mentioned the South Korean article.

The stories also included false or misleading claims.

U.S. News and World Report’s story said that it was an “incorrect idea that COVID-19 vaccines are linked to death in young people.”

NBC’s article said that the study “debunks widespread misinformation that the mRNA shots were connected to sudden cardiac death in young athletes.”

NBC reporter Berkeley Lovelace Jr. also wrote that “there is no evidence that COVID vaccines cause fatal cardiac arrest or other deadly heart problems in teens and young adults, a CDC report finds.”

“I don’t think that is close to an accurate assessment of the CDC paper or the overall level of knowledge we have about vaccine risk,” Dr. McCune said.

The reporters who wrote the articles for U.S. News and World Report, NBC, The Hill, and Medpage Today did not respond to requests for comment.

Other papers that support a link between deaths among young people and COVID-19 vaccination include a study that analyzed post-vaccination deaths in Qatar and determined there was a “high probability” that eight sudden cardiac deaths, including one person aged 11 to 20, were caused by the vaccination. Some death certificates have also described COVID-19 vaccine-induced myocarditis as a cause of death for sudden deaths, including the certificate for an American college student who died suddenly after receiving a Pfizer shot.

Authorities in the United States acknowledge that the COVID-19 vaccines can cause myocarditis but maintain no deaths have been caused by vaccine-induced myocarditis. They have refused to release autopsies conducted on people who died after COVID-19 vaccination. Several long-term studies have identified heart scarring in people who suffered myocarditis after COVID-19 vaccination. Some experts say the scarring may be permanent and could eventually lead to death.

Dr. Ofer Levy, an adviser to the U.S. Food and Drug Administration, told NBC that no vaccine has ever been conclusively linked to sudden cardiac death and that the new study “adds to evidence that people don’t drop dead from getting their mRNA COVID vaccines.” Dr. Levy did not respond when asked whether he was aware of the South Korean paper and other literature.

NBC also quoted Dr. Leslie Cooper in promoting the study while failing to note that Dr. Cooper is a consultant for Moderna.

Authors Respond

Asked why they didn’t mention literature that presents evidence of sudden cardiac death among previously healthy young people after vaccination, the authors told The Epoch Times in an email that they had. The studies they included are an Israeli paper that does not mention sudden death; a letter that noted sudden deaths among athletes, regardless of vaccination status, since the vaccines were rolled out; an analysis of 911 calls from Israel; and a case definition for myocarditis that says it can be a cause of sudden death. None of the papers cite autopsy data or other strong evidence that has emerged.

The authors also linked to a 2021 CDC statement and a 2021 CDC presentation, neither of which mention sudden death.

The authors did not say whether they were unaware of the South Korean study or chose not to include it.

The CDC should “not have published their study without acknowledging the international studies that have identified post-mRNA vax-related cardiac death in young people,” Dr. Tracy Hoeg, who was not involved in the research, wrote on the social media platform X.

In the paper, the authors also cited an earlier CDC study that found people who entered a health system were at higher risk of cardiac complications after COVID-19 infection versus after COVID-19 vaccination. The relevance isn’t clear since the COVID-19 vaccines do not prevent infection, and some other studies have found that the risk of myocarditis is higher after vaccination among young people.

Asked why they didn’t cite any of those other studies, the authors referred back to the papers they did cite and said they “also clearly expressed the limitations in the research.”

Limitations of the paper include the small population size, which would make it “less likely” for Oregon to record “a rare event such as sudden cardiac death among adolescents and young adults,” the authors wrote in the study.

“Nevertheless, it is clear that the risk, if any, of cardiac death linked to COVID-19 vaccination is very low, while the risk of dying from COVID-19 is real,” Dr. Cieslak said in a press release issued by the Oregon Health Authority. “We continue to recommend COVID-19 vaccination for all persons 6 months of age and older to prevent COVID-19 and complications, including death.”

The authority didn’t list any data that show the currently available vaccines prevent COVID-19 complications such as death. U.S. regulators cleared them in 2023 without clinical trial efficacy data. Only animal testing data was available for the Pfizer-BioNTech and Novavax shots. Moderna presented antibody data from 50 humans. Observational studies have since provided mixed effectiveness data against infection and hospitalization.

CDC Journal

The CDC published the study in its journal, Morbidity and Mortality Weekly Report (MMWR), which only publishes papers after officials shape them to align with the agency’s messaging. The CDC has been relentlessly promotive of the COVID-19 vaccines since they were rolled out.

Previous releases of documents under the Freedom of Information Act (FOIA) show that CDC officials engage in multiple rounds of editing of papers published in the journal.

The authors of the new paper acknowledged that the paper was edited prior to publication.

“CDC made no edits that altered the conclusions of the study,” they said.

The CDC journal’s editor-in-chief did not respond to a query.

The Epoch Times has filed FOIA requests to ascertain which edits were made, and by whom.

The authors also defended the choice to submit the paper to MMWR, rather than a traditional journal.

“Many times there is a large amount of observational data that is critical for time-sensitive reporting to inform public health practitioners and clinicians. These sorts of time-sensitive publications that might impact the actions of state and county public health leaders have long been published in the CDC’s MMWR,” they said. “In fact, there are numerous examples of CDC’s MMWR being the first source of information during many important historical events, including the beginning of the AIDS pandemic, the discovery of Legionnaires disease, the initial cases of H1N1 in 2009.”

Tyler Durden Sat, 04/13/2024 - 18:40

Read More

Continue Reading

Trending